Parallel Advisors
TFFP icon

Parallel Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Parallel Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-119
Closed -$3.11K – 3525
2022
Q4 		$3.11K Hold
119
– – ﹤0.01% 2517
2022
Q3 		$12K Hold
119
– – ﹤0.01% 1948
2022
Q2 		$17K Hold
119
– – ﹤0.01% 1749
2022
Q1 		$19K Hold
119
– – ﹤0.01% 1764
2021
Q4 		$26K Buy
+119
New +$23K ﹤0.01% 1666

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DRW Securities
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return

Parallel Advisors's TFFP Position: Q1 2023 in Review

Parallel Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2023, closing a stake of 119 shares — an estimated $3.11K sold.

Parallel Advisors first reported a position in TFFP in Q4 2021 and held it in 5 quarters. The position peaked at $26K in Q4 2021. 36 funds tracked by Wall St. Rank hold TFFP as of Q1 2023.

  • Parallel Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Parallel Advisors sold 119 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $3.11K.
  • Parallel Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Parallel Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $26K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.